The invention fully humanized monoclonal antibodies that neutralize Bacillus anthracis. Also provided are methods of treating or preventing a Bacillus anthracis infection. The invention also provides methods of passive vaccination of a subject against Bacillus anthracis.

 
Web www.patentalert.com

< Molecules with extended half-lives, compositions and uses thereof

> Bar composition comprising thermochromic pigment or dye signalling benefit agent release or other use

> Method and composition for administering an NMDA receptor antagonist to a subject
~ 00577